No one knows exactly how many people are affected by lipodystrophy worldwide, and clinical endpoints that could gauge the effectiveness of treatments are sparse. PR Web, 03/04/2014. (Also see: Lipodystrophy)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.